Impact of the COVID-19 pandemic on aortic valve replacement procedures in Germany.
Covid-19
TAVI
sAVR
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
06 04 2023
06 04 2023
Historique:
received:
13
08
2022
accepted:
29
03
2023
medline:
10
4
2023
entrez:
6
4
2023
pubmed:
7
4
2023
Statut:
epublish
Résumé
COVID-19 has caused the deferral of millions of elective procedures, likely resulting in a backlog of cases. We estimate the number of postponed surgical aortic valve replacement (sAVR) and transcatheter aortic valve replacement (TAVR) procedures during the first two waves of the COVID-19 pandemic in Germany. Using German national records, all isolated TAVR and sAVR procedures between 2007 and 2020 were identified. Using weekly TAVR and sAVR procedures between 2017 and 2019, we created a forecast for 2020 and compared it with the observed number of procedures in 2020. In Germany, a total of 225,398 isolated sAVR and 159,638 isolated TAVR procedures were conducted between 2007 and 2020 that were included in our analysis. The reduction in all AVR procedures (sAVR and TAVR) for the entire year 2020 was 19.07% (95%CI: 15.19-22.95%). During the first wave of the pandemic (week 12-21), the mean weekly reduction was 32.06% (23.44-40.68%) and during the second wave of the pandemic (week 41-52), the mean weekly reduction was 25.58% (14.19-36.97%). The number of sAVR procedures decreased more than the number of TAVR procedures (24.63% vs. 16.42% for the entire year 2020). The first year of the COVID-19 pandemic saw a substantial postponing of AVR procedures in Germany. Postponing was higher for sAVR than for TAVR procedures and less pronounced during the second wave of the COVID-19 pandemic.
Sections du résumé
BACKGROUND
COVID-19 has caused the deferral of millions of elective procedures, likely resulting in a backlog of cases. We estimate the number of postponed surgical aortic valve replacement (sAVR) and transcatheter aortic valve replacement (TAVR) procedures during the first two waves of the COVID-19 pandemic in Germany.
METHODS
Using German national records, all isolated TAVR and sAVR procedures between 2007 and 2020 were identified. Using weekly TAVR and sAVR procedures between 2017 and 2019, we created a forecast for 2020 and compared it with the observed number of procedures in 2020.
RESULTS
In Germany, a total of 225,398 isolated sAVR and 159,638 isolated TAVR procedures were conducted between 2007 and 2020 that were included in our analysis. The reduction in all AVR procedures (sAVR and TAVR) for the entire year 2020 was 19.07% (95%CI: 15.19-22.95%). During the first wave of the pandemic (week 12-21), the mean weekly reduction was 32.06% (23.44-40.68%) and during the second wave of the pandemic (week 41-52), the mean weekly reduction was 25.58% (14.19-36.97%). The number of sAVR procedures decreased more than the number of TAVR procedures (24.63% vs. 16.42% for the entire year 2020).
CONCLUSION
The first year of the COVID-19 pandemic saw a substantial postponing of AVR procedures in Germany. Postponing was higher for sAVR than for TAVR procedures and less pronounced during the second wave of the COVID-19 pandemic.
Identifiants
pubmed: 37024779
doi: 10.1186/s12872-023-03213-y
pii: 10.1186/s12872-023-03213-y
pmc: PMC10079149
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
187Informations de copyright
© 2023. The Author(s).
Références
Front Public Health. 2021 Jan 13;8:594117
pubmed: 33520914
N Engl J Med. 2015 Dec 17;373(25):2438-47
pubmed: 26672846
Circ Cardiovasc Interv. 2021 May;14(5):e010413
pubmed: 34003671
Int J Cardiol. 2017 May 15;235:17-21
pubmed: 28274581
Catheter Cardiovasc Interv. 2020 Mar 1;95(4):810-816
pubmed: 31165569
Circulation. 2018 Nov 13;138(20):2298-2300
pubmed: 30571518
J Crit Care. 2020 Apr;56:100-105
pubmed: 31896442
Eur Neurol. 2020;83(2):213-215
pubmed: 32289789
G Ital Cardiol (Rome). 2020 Nov;21(11 Suppl 1):45S-47S
pubmed: 33295334
Am J Med. 2017 Mar;130(3):253-263
pubmed: 27810479
Eur J Epidemiol. 2020 Dec;35(12):1123-1138
pubmed: 33289900
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2137-2143
pubmed: 27765308
Clin Cardiol. 2021 Jul;44(7):890-898
pubmed: 34075604
EuroIntervention. 2017 Dec 20;13(11):1281-1287
pubmed: 28870876
Heart. 2013 Mar;99(6):396-400
pubmed: 22942293
Clin Res Cardiol. 2023 Apr;112(4):550-557
pubmed: 36198827